Acer Therapeutics Inc.·4

Sep 25, 2:20 PM ET

Klopp John Michael 4

4 · Acer Therapeutics Inc. · Filed Sep 25, 2019

Insider Transaction Report

Form 4
Period: 2019-09-18
Klopp John Michael
Chief Technology Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2019-09-18+50,00050,000 total
    Exercise: $3.42Exp: 2029-09-18Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable as follows: 50% on 01/01/2021 and 50% on 01/01/2022.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION